Compare Dishman Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ELDER PHARMA - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ELDER PHARMA DISHMAN PHARMA/
ELDER PHARMA
 
P/E (TTM) x 25.1 -0.2 - View Chart
P/BV x 3.3 0.1 3,316.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ELDER PHARMA
Jun-14
DISHMAN PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs374380 98.5%   
Low Rs129188 68.6%   
Sales per share (Unadj.) Rs197.8491.2 40.3%  
Earnings per share (Unadj.) Rs21.2-3.2 -666.5%  
Cash flow per share (Unadj.) Rs34.714.4 241.0%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.9376.5 47.8%  
Shares outstanding (eoy) m80.6920.54 392.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.6 220.0%   
Avg P/E ratio x11.9-89.3 -13.3%  
P/CF ratio (eoy) x7.219.7 36.8%  
Price / Book Value ratio x1.40.8 185.5%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3065,833 348.1%   
No. of employees `0000.8NA-   
Total wages/salary Rs m5,3552,179 245.8%   
Avg. sales/employee Rs Th19,252.7NM-  
Avg. wages/employee Rs Th6,459.5NM-  
Avg. net profit/employee Rs Th2,064.1NM-  
INCOME DATA
Net Sales Rs m15,96110,089 158.2%  
Other income Rs m265257 103.4%   
Total revenues Rs m16,22610,346 156.8%   
Gross profit Rs m4,103-792 -518.1%  
Depreciation Rs m1,091361 301.9%   
Interest Rs m9442,756 34.3%   
Profit before tax Rs m2,334-3,653 -63.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m624125 498.3%   
Profit after tax Rs m1,711-65 -2,618.4%  
Gross profit margin %25.7-7.8 -327.5%  
Effective tax rate %26.7-3.4 -780.0%   
Net profit margin %10.7-0.6 -1,655.1%  
BALANCE SHEET DATA
Current assets Rs m11,0189,240 119.2%   
Current liabilities Rs m9,5179,998 95.2%   
Net working cap to sales %9.4-7.5 -125.2%  
Current ratio x1.20.9 125.3%  
Inventory Days Days11046 238.6%  
Debtors Days Days3560 58.1%  
Net fixed assets Rs m16,30410,124 161.0%   
Share capital Rs m161206 78.5%   
"Free" reserves Rs m12,9075,582 231.2%   
Net worth Rs m14,5167,734 187.7%   
Long term debt Rs m4,1894,889 85.7%   
Total assets Rs m29,80522,882 130.3%  
Interest coverage x3.5-0.3 -1,067.0%   
Debt to equity ratio x0.30.6 45.7%  
Sales to assets ratio x0.50.4 121.5%   
Return on assets %8.911.8 75.8%  
Return on equity %11.8-0.8 -1,395.0%  
Return on capital %17.522.3 78.6%  
Exports to sales %24.83.0 815.7%   
Imports to sales %3.70.4 874.6%   
Exports (fob) Rs m3,956307 1,290.3%   
Imports (cif) Rs m59643 1,383.5%   
Fx inflow Rs m4,952307 1,615.0%   
Fx outflow Rs m697125 556.1%   
Net fx Rs m4,255181 2,346.8%   
CASH FLOW
From Operations Rs m2,78611,754 23.7%  
From Investments Rs m-1,529-561 272.8%  
From Financial Activity Rs m-941-6,762 13.9%  
Net Cashflow Rs m3164,432 7.1%  

Share Holding

Indian Promoters % 61.4 39.6 155.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 7.5 49.3%  
FIIs % 12.7 16.8 75.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 36.1 61.2%  
Shareholders   46,261 16,479 280.7%  
Pledged promoter(s) holding % 35.8 77.6 46.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   CIPLA  PFIZER  NATCO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare DISHMAN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 428 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended their trading session on a positive note today.

Related Views on News

Most Popular

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

How to Become a One Stock Crorepati(Profit Hunter)

Feb 6, 2020

A little known Indian stock that is set to turn around its own fortunes, and your wealth, if you just have the foresight to get in on time...

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

How to Use Stop Losses in Your Trading(Fast Profits Daily)

Feb 13, 2020

There's more to stop losses than just limiting a trading loss. Find out more...

No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 5-YR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS